Crossmark Global Holdings Inc. Raises Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Crossmark Global Holdings Inc. boosted its stake in shares of Henry Schein, Inc. (NASDAQ:HSICFree Report) by 1.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,090 shares of the company’s stock after buying an additional 197 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Henry Schein were worth $991,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in HSIC. Aurora Investment Counsel lifted its holdings in shares of Henry Schein by 0.7% in the 3rd quarter. Aurora Investment Counsel now owns 20,641 shares of the company’s stock worth $1,533,000 after acquiring an additional 140 shares during the last quarter. Arizona State Retirement System raised its position in Henry Schein by 0.4% in the fourth quarter. Arizona State Retirement System now owns 35,890 shares of the company’s stock valued at $2,717,000 after purchasing an additional 149 shares during the period. Wahed Invest LLC lifted its stake in Henry Schein by 11.3% during the third quarter. Wahed Invest LLC now owns 2,035 shares of the company’s stock worth $151,000 after purchasing an additional 206 shares in the last quarter. Treasurer of the State of North Carolina boosted its position in shares of Henry Schein by 0.4% during the third quarter. Treasurer of the State of North Carolina now owns 66,473 shares of the company’s stock worth $4,936,000 after buying an additional 242 shares during the period. Finally, Covestor Ltd grew its stake in shares of Henry Schein by 22.8% in the third quarter. Covestor Ltd now owns 1,367 shares of the company’s stock valued at $102,000 after buying an additional 254 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Henry Schein

In related news, Vice Chairman James P. Breslawski sold 2,907 shares of the stock in a transaction on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the transaction, the insider now directly owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the transaction, the chief executive officer now owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the sale, the insider now directly owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on HSIC. Barrington Research increased their target price on Henry Schein from $90.00 to $92.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 8th. JPMorgan Chase & Co. raised their price objective on shares of Henry Schein from $82.00 to $88.00 and gave the company an “overweight” rating in a research note on Wednesday, March 6th. Evercore ISI upped their target price on shares of Henry Schein from $79.00 to $83.00 and gave the stock an “in-line” rating in a research note on Wednesday, February 28th. Jefferies Financial Group raised their price target on shares of Henry Schein from $74.00 to $81.00 and gave the company a “hold” rating in a research report on Wednesday, March 6th. Finally, Piper Sandler upped their price objective on Henry Schein from $78.00 to $86.00 and gave the stock an “overweight” rating in a research report on Monday, February 26th. One analyst has rated the stock with a sell rating, six have issued a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $81.73.

Read Our Latest Research Report on Henry Schein

Henry Schein Stock Down 1.6 %

Henry Schein stock opened at $67.42 on Tuesday. The stock’s fifty day moving average is $71.46 and its two-hundred day moving average is $73.25. The stock has a market cap of $8.63 billion, a PE ratio of 22.78, a P/E/G ratio of 1.72 and a beta of 0.90. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $82.63. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.75 and a quick ratio of 1.02.

Henry Schein (NASDAQ:HSICGet Free Report) last issued its earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.01 by $0.09. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.21 billion. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The business’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter last year, the company earned $1.21 EPS. On average, sell-side analysts expect that Henry Schein, Inc. will post 5.09 EPS for the current fiscal year.

Henry Schein Company Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Recommended Stories

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.